Live Breaking News & Updates on Sglt 2 Inhibitors

Stay updated with breaking news from Sglt 2 inhibitors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SGLT2 inhibitors reduce recurrent flares and hospitalizations in patients with gout

1. In this population cohort study, patients with gout who used sodium-glucose cotransporter-2 inhibitors (SGLT2is) experienced fewer recurrent flares than those using dipeptidyl peptidase 4 inhibitors (DPP-4is). 2. Those who used SGLT2 inhibitors also presented to the emergency department (ED) less frequently for gout-related visits than those using DPP-4is. Evidence Rating Level: 1 (Excellent) Study ....

United Kingdom , International Statistical Classification Of Diseases , Health Problems , Minute Medicine Inc , Rating Level , Gout With Sodium , Patients With Type , British Columbia , International Statistical Classification , Related Health Problems , Confidence Interval , Chronic Disease , Dipeptidyl Peptidase 4 Inhibitors , Inflammatory Arthritis , Sglt 2 Inhibitors , Sodium Glucose Cotransporter 2 Inhibitors ,

Quadruple Therapy for Patients With Heart Failure

An expert cardiologist reviews the foundational pillars of quadruple-based, guideline therapies for heart failure, as well as the contraindications for these drugs. ....

Anuradha Lala Trindade , Heart Failure , Left Ventricle Ejection Fraction Ef , Contraindications To Quadruple Therapy , Quadruple Therapy , Sglt 2 Inhibitors ,

Use of SGLT-2 Inhibitors in Heart Failure

Anuradha Lala-Trindade, MD, provides an overview of SGLT2 inhibitors for the management of heart failure, as well as their clinical trial data. ....

Anuradha Lala Trindade , Heart Failure , Left Ventricle Ejection Fraction Ef , Sglt 2 Inhibitors , Quadruple Therapy ,